CliffBio
small molecule

TRIPTODUR KIT

TRIPTORELIN PAMOATE

Loss of exclusivityJune 2029latest FDA-listed patent expiry
CompanyAzurity Pharmaceuticals →View the full company profile on CliffBio

Drug detail

Brand nameTRIPTODUR KIT
Active ingredientTRIPTORELIN PAMOATE
StrengthEQ 22.5MG BASE/VIAL
Dosage formFOR SUSPENSION, EXTENDED RELEASE
RouteINTRAMUSCULAR
ModalitySmall molecule
FDA approvalJune 2017
Marketing statusRX

Listed patents

PatentExpiresType
10166181June 2029product

More from Azurity Pharmaceuticals

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

TRIPTODUR KIT patent cliff — loss of exclusivity June 2029 | CliffBio